The effect of rhIL-37 protein could not be tested in CCl4-induced liver fibrosis or during chronic colitis due to the long-term nature of both models during which subcutaneous or i.p. injections would have induced an antibody response against human IL-37 protein. The gene discussed is IL37; the disease is Hepatic fibrosis.